Zim Laboratories

43
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE518E01015
  • NSEID: ZIMLAB
  • BSEID: 541400
INR
111.80
0.25 (0.22%)
BSENSE

Jun 16, 10:29 AM

BSE+NSE Vol: 13.57 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Zim Laboratories Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
8.00
18.00
23.00
35.00
21.00
15.00
Adjustment
29.00
32.00
22.00
22.00
22.00
25.00
Changes In working Capital
15.00
-10.00
-26.00
-12.00
6.00
-8.00
Cash Flow after changes in Working Capital
53.00
40.00
18.00
45.00
49.00
32.00
Cash Flow from Operating Activities
49.00
41.00
16.00
38.00
49.00
31.00
Cash Flow from Investing Activities
-54.00
-39.00
-72.00
-35.00
-14.00
-5.00
Cash Flow from Financing Activities
28.00
-9.00
59.00
0.00
-32.00
-25.00
Net Cash Inflow / Outflow
23.00
-7.00
3.00
3.00
2.00
0.00
Opening Cash & Cash Equivalents
1.00
9.00
6.00
3.00
1.00
1.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
25.00
1.00
9.00
6.00
3.00
1.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Zim Laboratories
Markets Mojo
Figures in Cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
8.21
34.47
-26.00
-76.18%
Adjustment
29.1
1.16
28.00
2408.62%
Changes In working Capital
15.96
-9.63
24.00
265.73%
Cash Flow after changes in Working Capital
53.27
26.01
27.00
104.81%
Cash Flow from Operating Activities
49.53
17.54
32.00
182.38%
Cash Flow from Investing Activities
-54.54
-39.95
-15.00
-36.52%
Cash Flow from Financing Activities
28.19
13.24
15.00
112.92%
Net Cash Inflow / Outflow
23.18
-9.16
32.00
353.06%
Opening Cash & Cash Equivalents
1.95
18.96
-17.00
-89.72%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
25.12
9.8
16.00
156.33%
Cash Flow - Snapshot (Consolidated) - Mar'26
stock-summary

YoY Growth in year ended Mar 2026 is 20.36% vs 152.76% in Mar 2025

Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
49.53
41.15
20.36%